Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling

This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone...

Full description

Saved in:
Bibliographic Details
Published inGenetics in medicine Vol. 9; no. 8; pp. 487 - 495
Main Authors Jenkins, Jean, Calzone, Kathleen A., Dimond, Eileen, Liewehr, David J., Steinberg, Seth M., Jourkiv, Oxana, Klein, Pam, Soballe, Peter W., Prindiville, Sheila A., Kirsch, Ilan R.
Format Journal Article
LanguageEnglish
Published United States 01.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
AbstractList This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.PURPOSEThis study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing.A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure.METHODSA total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure.There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure.RESULTSThere were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure.These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.CONCLUSIONSThese data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. Methods: A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Date from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. Results: There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. Conclusions: These date suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
Author Jourkiv, Oxana
Prindiville, Sheila A.
Calzone, Kathleen A.
Jenkins, Jean
Kirsch, Ilan R.
Dimond, Eileen
Klein, Pam
Soballe, Peter W.
Liewehr, David J.
Steinberg, Seth M.
Author_xml – sequence: 1
  givenname: Jean
  surname: Jenkins
  fullname: Jenkins, Jean
– sequence: 2
  givenname: Kathleen A.
  surname: Calzone
  fullname: Calzone, Kathleen A.
– sequence: 3
  givenname: Eileen
  surname: Dimond
  fullname: Dimond, Eileen
– sequence: 4
  givenname: David J.
  surname: Liewehr
  fullname: Liewehr, David J.
– sequence: 5
  givenname: Seth M.
  surname: Steinberg
  fullname: Steinberg, Seth M.
– sequence: 6
  givenname: Oxana
  surname: Jourkiv
  fullname: Jourkiv, Oxana
– sequence: 7
  givenname: Pam
  surname: Klein
  fullname: Klein, Pam
– sequence: 8
  givenname: Peter W.
  surname: Soballe
  fullname: Soballe, Peter W.
– sequence: 9
  givenname: Sheila A.
  surname: Prindiville
  fullname: Prindiville, Sheila A.
– sequence: 10
  givenname: Ilan R.
  surname: Kirsch
  fullname: Kirsch, Ilan R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/17700386$$D View this record in MEDLINE/PubMed
BookMark eNqFUctO3TAQtSqq8mj_oEJedRcYP67tsKNXvCQqJETXlq8zoUaJHeykUvl6fAVlwaJdzWjOw-M5-2QnpoiEfGVwxKDVxxdXP45gA0ygYIZxVJzDB7LHVgIaEErt1B5a0wgFsEv2S3kAYFpw-ER2mdYAwqg9Mt262KUxPGFHfRonl0NJkaaeTr_qe_Q35rIUGmIz1a4i32_Xp-yY0yljF8qUSphDHd9jxDl4OmOZacayDDOtuB9SWTJW6yUWHEK8_0w-9m4o-OW1HpCf52d368vm-ubian163Xhh-Nxw2UsvZdtyIY13humuZT1C26-QG2S46qRwG837duMkKuSt2f7IO62lrtgB-fbiO-X0uNSt7FjXwWFwEdNSrDJMyZVQ_yVyAMmqdSUevhKXzYidnXIYXf5j_x6zEk5eCD6nUjL21ofZbc8zZxcGy8Buk7M1Ofs-uSqW78Rv_v-SPQNJIJ2O
CitedBy_id crossref_primary_10_1007_s11606_018_4655_8
crossref_primary_10_1016_j_pec_2012_06_009
crossref_primary_10_1002_ajmg_c_30219
crossref_primary_10_1016_j_suc_2008_05_003
crossref_primary_10_3390_cancers10110424
crossref_primary_10_1016_j_jalz_2014_10_014
crossref_primary_10_1007_s10897_009_9238_8
crossref_primary_10_1007_s10897_011_9355_z
crossref_primary_10_1111_j_1399_0004_2011_01813_x
crossref_primary_10_1002_jgc4_1694
crossref_primary_10_1007_s10897_017_0082_y
crossref_primary_10_1136_jmedgenet_2015_103740
crossref_primary_10_1111_j_1399_0004_2011_01811_x
crossref_primary_10_1002_jgc4_1630
crossref_primary_10_1111_j_1524_4741_2009_00800_x
crossref_primary_10_1007_s10897_011_9462_x
crossref_primary_10_32725_kont_2021_035
crossref_primary_10_2196_resprot_3337
crossref_primary_10_1007_s10897_013_9655_6
crossref_primary_10_1007_s10897_015_9887_8
crossref_primary_10_1200_JCO_2013_51_3226
crossref_primary_10_1007_s10897_015_9848_2
crossref_primary_10_1007_s10689_012_9522_x
crossref_primary_10_1002_ajmg_c_30308
crossref_primary_10_1111_ecc_13435
crossref_primary_10_1016_j_pec_2013_08_009
crossref_primary_10_1002_jgc4_1481
crossref_primary_10_1007_s10897_017_0073_z
crossref_primary_10_1158_1055_9965_EPI_19_2_ASPO01
crossref_primary_10_1002_jgc4_1343
crossref_primary_10_1089_gte_2007_0525
crossref_primary_10_1002_jgc4_1441
crossref_primary_10_1007_s10689_016_9900_x
crossref_primary_10_1007_s10689_009_9303_3
crossref_primary_10_1111_j_1399_0004_2010_01466_x
crossref_primary_10_1089_gte_2006_0525
crossref_primary_10_1016_j_trci_2017_02_004
crossref_primary_10_1111_cge_13474
crossref_primary_10_1111_j_1399_0004_2010_01540_x
crossref_primary_10_1002_jgc4_1627
crossref_primary_10_1007_s10897_012_9505_y
crossref_primary_10_1188_13_CJON_397_404
crossref_primary_10_3389_fonc_2016_00120
crossref_primary_10_1159_000496556
crossref_primary_10_1016_j_trci_2019_09_013
crossref_primary_10_1093_jnci_djy015
crossref_primary_10_1007_s10689_010_9326_9
crossref_primary_10_1007_s10897_017_0183_7
Cites_doi 10.1136/jmg.31.7.555
ContentType Journal Article
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
8FD
FR3
P64
RC3
7X8
DOI 10.1097/GIM.0b013e31812e6220
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1530-0366
EndPage 495
ExternalDocumentID 17700386
10_1097_GIM_0b013e31812e6220
Genre Comparative Study
Research Support, N.I.H., Intramural
Randomized Controlled Trial
Journal Article
GrantInformation_xml – fundername: Intramural NIH HHS
GroupedDBID ---
.-D
..I
.GJ
08G
39C
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
70F
7X7
88E
8FI
8FJ
AAFWJ
AAKAS
AALRI
AAXUO
AAYEP
AAYWO
AAYXX
ABAWZ
ABJNI
ABLJU
ABUWG
ACGFO
ACGFS
ACKTT
ACRQY
ACVFH
ADBBV
ADBIZ
ADCNI
ADVLN
ADZCM
AE3
AEJRE
AENEX
AEUPX
AEXYK
AFETI
AFJKZ
AFKRA
AFPUW
AFSHS
AFTRI
AGAYW
AGCQF
AHMBA
AHSBF
AHVBC
AIGII
AILAN
AITUG
AIZYK
AJRNO
AKBMS
AKRWK
AKYEP
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
AXYYD
BENPR
BKKNO
BPHCQ
BS7
BVXVI
CCPQU
CITATION
CS3
DNIVK
DU5
EBS
EE.
EIOEI
EJD
EX3
F5P
FDB
FDQFY
FERAY
FIZPM
FSGXE
FYUFA
H0~
HMCUK
JF9
JG8
JK3
JSO
K-O
KD2
M1P
M41
N9A
NQJWS
N~M
OAG
OAH
ODA
OK1
OLG
OVD
OWU
OWV
OWW
OWX
OWY
OWZ
P-K
P2P
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
R58
RNT
RNTTT
ROL
S4R
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
T8P
TAOOD
TBHMF
TDRGL
TEORI
TSG
UKHRP
VVN
W3M
WOQ
WOW
XXN
XYM
YFH
ZFV
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
PJZUB
PPXIY
8FD
FR3
P64
RC3
7X8
ID FETCH-LOGICAL-c382t-24f4c44992348ca817d91fe09f5e28e1e5d43ab72f9ba4e6e2980386ca7747d43
ISSN 1098-3600
1530-0366
IngestDate Mon Jul 21 11:08:17 EDT 2025
Fri Jul 11 11:49:58 EDT 2025
Mon Jul 21 06:03:23 EDT 2025
Thu Apr 24 23:08:51 EDT 2025
Tue Jul 01 02:58:59 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c382t-24f4c44992348ca817d91fe09f5e28e1e5d43ab72f9ba4e6e2980386ca7747d43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ObjectType-Undefined-3
OpenAccessLink http://www.gimjournal.org/article/S1098360021038909/pdf
PMID 17700386
PQID 20041038
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_68164536
proquest_miscellaneous_20041038
pubmed_primary_17700386
crossref_citationtrail_10_1097_GIM_0b013e31812e6220
crossref_primary_10_1097_GIM_0b013e31812e6220
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2007-08-01
PublicationDateYYYYMMDD 2007-08-01
PublicationDate_xml – month: 08
  year: 2007
  text: 2007-08-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Genetics in medicine
PublicationTitleAlternate Genet Med
PublicationYear 2007
References Stone (10.1097/GIM.0b013e31812e6220_bb0155)
Schwartz (10.1097/GIM.0b013e31812e6220_bb0100)
Wooster (10.1097/GIM.0b013e31812e6220_bb0030)
10.1097/GIM.0b013e31812e6220_bb0055
10.1097/GIM.0b013e31812e6220_bb0110
Ormond (10.1097/GIM.0b013e31812e6220_bb0090)
Biesecker (10.1097/GIM.0b013e31812e6220_bb0050)
10.1097/GIM.0b013e31812e6220_bb0115
Melzer (10.1097/GIM.0b013e31812e6220_bb0175)
Zilberg (10.1097/GIM.0b013e31812e6220_bb0135)
Dimond (10.1097/GIM.0b013e31812e6220_bb0035) 2003
Hughes (10.1097/GIM.0b013e31812e6220_bb0150)
Miki (10.1097/GIM.0b013e31812e6220_bb0020)
Claus (10.1097/GIM.0b013e31812e6220_bb0015)
Calzone (10.1097/GIM.0b013e31812e6220_bb0045)
Braithwaite (10.1097/GIM.0b013e31812e6220_bb0165)
McBride (10.1097/GIM.0b013e31812e6220_bb0075)
10.1097/GIM.0b013e31812e6220_bb0010
Horowitz (10.1097/GIM.0b013e31812e6220_bb0130)
Sangha (10.1097/GIM.0b013e31812e6220_bb0095)
Lerman (10.1097/GIM.0b013e31812e6220_bb0140)
10.1097/GIM.0b013e31812e6220_bb0125
Helmes (10.1097/GIM.0b013e31812e6220_bb0080)
Bluman (10.1097/GIM.0b013e31812e6220_bb0145)
van Oostrom (10.1097/GIM.0b013e31812e6220_bb0040)
Tavtigian (10.1097/GIM.0b013e31812e6220_bb0025)
10.1097/GIM.0b013e31812e6220_bb0060
Craig (10.1097/GIM.0b013e31812e6220_bb0170)
Calzone (10.1097/GIM.0b013e31812e6220_bb0105)
Wang (10.1097/GIM.0b013e31812e6220_bb0070)
Coyne (10.1097/GIM.0b013e31812e6220_bb0160)
10.1097/GIM.0b013e31812e6220_bb0120
Thompson (10.1097/GIM.0b013e31812e6220_bb0065)
Campbell (10.1097/GIM.0b013e31812e6220_bb0085)
References_xml – ident: 10.1097/GIM.0b013e31812e6220_bb0055
– ident: 10.1097/GIM.0b013e31812e6220_bb0060
  doi: 10.1136/jmg.31.7.555
– ident: 10.1097/GIM.0b013e31812e6220_bb0070
– ident: 10.1097/GIM.0b013e31812e6220_bb0110
– ident: 10.1097/GIM.0b013e31812e6220_bb0015
– ident: 10.1097/GIM.0b013e31812e6220_bb0095
– ident: 10.1097/GIM.0b013e31812e6220_bb0120
– ident: 10.1097/GIM.0b013e31812e6220_bb0140
– ident: 10.1097/GIM.0b013e31812e6220_bb0050
– ident: 10.1097/GIM.0b013e31812e6220_bb0165
– ident: 10.1097/GIM.0b013e31812e6220_bb0020
– ident: 10.1097/GIM.0b013e31812e6220_bb0100
– ident: 10.1097/GIM.0b013e31812e6220_bb0150
– ident: 10.1097/GIM.0b013e31812e6220_bb0065
– ident: 10.1097/GIM.0b013e31812e6220_bb0155
– ident: 10.1097/GIM.0b013e31812e6220_bb0090
– ident: 10.1097/GIM.0b013e31812e6220_bb0045
– ident: 10.1097/GIM.0b013e31812e6220_bb0160
– ident: 10.1097/GIM.0b013e31812e6220_bb0175
– ident: 10.1097/GIM.0b013e31812e6220_bb0170
– ident: 10.1097/GIM.0b013e31812e6220_bb0115
– ident: 10.1097/GIM.0b013e31812e6220_bb0025
– ident: 10.1097/GIM.0b013e31812e6220_bb0080
– ident: 10.1097/GIM.0b013e31812e6220_bb0075
– ident: 10.1097/GIM.0b013e31812e6220_bb0085
– ident: 10.1097/GIM.0b013e31812e6220_bb0010
– ident: 10.1097/GIM.0b013e31812e6220_bb0130
– ident: 10.1097/GIM.0b013e31812e6220_bb0145
– ident: 10.1097/GIM.0b013e31812e6220_bb0125
– ident: 10.1097/GIM.0b013e31812e6220_bb0135
– ident: 10.1097/GIM.0b013e31812e6220_bb0105
– start-page: 225
  year: 2003
  ident: 10.1097/GIM.0b013e31812e6220_bb0035
  article-title: Establishing a cancer genetics clinic
– ident: 10.1097/GIM.0b013e31812e6220_bb0040
– ident: 10.1097/GIM.0b013e31812e6220_bb0030
SSID ssj0017320
Score 2.0868924
Snippet This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. A...
Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic...
This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 487
SubjectTerms Adult
Aged
Anxiety - etiology
Anxiety - psychology
Apoptosis Regulatory Proteins
BRCA1 Protein - genetics
BRCA2 Protein - genetics
Female
Genetic Counseling
Genetic Predisposition to Disease - psychology
Humans
Male
Middle Aged
Patient Satisfaction
Telephone
Title Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling
URI https://www.ncbi.nlm.nih.gov/pubmed/17700386
https://www.proquest.com/docview/20041038
https://www.proquest.com/docview/68164536
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdKJxAvCMZX-fQDb1G6xHES57FUY6OjPFSb2FvlOI5WqTTVlmqifwp_LXexk7RlA8ZLVDmx6_Z-sc93v7sj5APmwOKeTl3MJYemG3jnRBq6MpaYbU4JpTF2ePw1Oj7jo_PwvNP5ucFaWpVpX61vjCv5H6lCG8gVo2TvINlmUGiAzyBfuIKE4fpPMp7IRVZ8n611Zrnktp6gg4Rz7SDjYoV8K3dZ6dXOx8lwUAVnYGqAbNYwtrCOMgYzOqB3lg4cwFfzEl03al6gAdFRTeD6pi57ZDpVhNpdF_1IY0kGGyvWAnAo5-vC2FBrGocz6DfKNODG2LkPZ3irbv8y09f64rKh4Duj_paxIm6ocvX6iulLg8jzNhfgZANnYmMx5XYrNvsyN8U4f1vyTSrho8_j1qbrMx0x5rVbXO3W39n5Gj5i7YmHUaa7o9wjewyOIKxL9gYnk28njY8qDpjJdWF_Uh2YmcQHN81mW_G55TRTaTWnj8kjexyhA4OtJ6SjF_vkvilQ-mOfPBhbuT4lyxZstAUbLXJagY0asNEGbLQC2wGj21CjFmoUoUYN1GgLNdpC7Rk5-3R4Ojx2bbkOVwWClS7jOVccTtAs4EJJ4cdZ4ufaS_JQM6F9HWY8kGnM8iSVXEeaJcILRKQkHEFiuPecdBcw4ZeEejxLoRuPFA85khUk2ieVFyiJpWJ0jwT1fzlVNpc9llSZT_8kyR5xm15Lk8vlL8-_r8U0hUUXPWlyoYvVFdZuxWmJ25-IhB_xMIh65IWRb_uNcYzu-OjVHWfzmjxs36g3pFtervRbUIjL9J1F5i9DKLNo
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Randomized+comparison+of+phone+versus+in-person+BRCA1%2F2+predisposition+genetic+test+result+disclosure+counseling&rft.jtitle=Genetics+in+medicine&rft.au=Jenkins%2C+Jean&rft.au=Calzone%2C+Kathleen+A.&rft.au=Dimond%2C+Eileen&rft.au=Liewehr%2C+David+J.&rft.date=2007-08-01&rft.issn=1098-3600&rft.volume=9&rft.issue=8&rft.spage=487&rft.epage=495&rft_id=info:doi/10.1097%2FGIM.0b013e31812e6220&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_GIM_0b013e31812e6220
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-3600&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-3600&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-3600&client=summon